Remote Monitoring

Remote cardiac monitoring technologies enable patient health to be tracked outside the clinical setting. It can be used for longer term monitoring to help diagnosis arrhythmias or other cardiac conditions. Remote monitoring also can keep tabs on chronic conditions such as heart failure or hypertension and alert clinicians to worsening symptoms to avoid an acute care episode or hospitalization.

Boston Scientific partners with Epic on data integration
The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.
FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring
According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.
U.S. International Federal Trade Commission reviews ban on new Apple Watch pulse oximeter
Masimo’s complaint over the new version of the Apple Watch could lead to an import ban if it is found that the technology infringes on its patents.
UnitedHealthcare bucks Medicare, ends reimbursement for most RPM services
Starting in 2026, patients covered by UnitedHealthcare's Medicare Advantage and commercial plans will not have care reimbursed for instances of remote patient monitoring unless they have diagnosed heart failure or are pregnant and experiencing hypertension. The shift stands at odds with traditional Medicare, which added new claims codes for providers to use next year.
Insulin pumps recalled due to malfunction risk—users warned to update software
The new Class I recall covers nearly 18,000 insulin pumps distributed throughout the United States. While this is not a product removal, users are being urged to update their devices immediately.

Boston Scientific partners with Epic on data integration

The collaboration allows providers to order diagnostic tests and then receive results directly in Epic.

FDA clears new ‘smart shirt’ for real-time cardiopulmonary monitoring

According to Hexoskin, the newly cleared technology offers significant value for hospitals and health systems as well as researchers conducting clinical trials.

Apple has officially introduced the Apple Watch Ultra 3, which will provide notifications when it detects signs of chronic high blood pressure once the technology is cleared by the U.S. Food and Drug Administration (FDA).

U.S. International Federal Trade Commission reviews ban on new Apple Watch pulse oximeter

Masimo’s complaint over the new version of the Apple Watch could lead to an import ban if it is found that the technology infringes on its patents.

UnitedHealthcare bucks Medicare, ends reimbursement for most RPM services

Starting in 2026, patients covered by UnitedHealthcare's Medicare Advantage and commercial plans will not have care reimbursed for instances of remote patient monitoring unless they have diagnosed heart failure or are pregnant and experiencing hypertension. The shift stands at odds with traditional Medicare, which added new claims codes for providers to use next year.

Insulin pumps recalled due to malfunction risk—users warned to update software

The new Class I recall covers nearly 18,000 insulin pumps distributed throughout the United States. While this is not a product removal, users are being urged to update their devices immediately.

FDA highlights risks of evaluating blood pressure with unauthorized medical devices

The agency emphasized that many over-the-counter technologies marketed for this purpose have not been properly evaluated.

The U.S. Food and Drug Administration (FDA) cleared a smart watch artificial intelligence (AI) algorithm that tells wearers if they are suspected of having hypertension, which is expected to help notify about 1 million users over the next year. This a is a new feature of the newly launched Apple Watch Ultra 3, which the company unveiled Sept. 9. Apple gained FDA for its Cardiovascular Machine Learning-Based Notification Software Hypertension Notification Feature (HTNF) Sept. 11, 2025.

FDA clears Apple Watch algorithm for detecting hypertension

The FDA’s decision arrived just days after Apple announced the new feature. "This tool empowers patients and clinicians to work together, putting prevention at the center of care," one cardiologist told Cardiovascular Business.

The Dexcom G7 Continuous Glucose Monitoring System

Dexcom issues new recall for CGM apps due to safety risk—users urged to update immediately

The FDA has categorized this as a Class I recall. If patients update their phone or watch apps as needed, they can continue to use these devices like normal.